SDIX Stockholders Approve Sale of Life Science Assets to OriGene Technologies

Published: Jul 11, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEWARK, Del.--(BUSINESS WIRE)--SDIX™ (NASDAQ: SDIX), a leading provider of biotechnology-based products and services, today announced the results of its Special Meeting of Stockholders held today. The Company reported that more than 65% percent of the outstanding shares entitled to vote thereon voted to approve the sale of the assets of the Company’s Life Sciences and Advanced Technologies businesses to a wholly owned subsidiary of OriGene.

Help employers find you! Check out all the jobs and post your resume.

Back to news